Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial
- PMID: 37364280
- PMCID: PMC10492240
- DOI: 10.1164/rccm.202301-0034OC
Thiamine for Renal Protection in Septic Shock (TRPSS): A Randomized, Placebo-controlled, Clinical Trial
Abstract
Rationale: Kidney injury is common and associated with worse outcomes in patients with septic shock. Mitochondrial resuscitation with thiamine (vitamin B1) may attenuate septic kidney injury. Objectives: To assess whether thiamine supplementation attenuates kidney injury in septic shock. Methods: The TRPSS (Thiamine for Renal Protection in Septic Shock) trial was a multicenter, randomized, placebo-controlled trial of thiamine versus placebo in septic shock. The primary outcome was change in serum creatinine between enrollment and 72 hours after enrollment. Measurements and Main Results: Eighty-eight patients were enrolled (42 patients received the intervention, and 46 received placebo). There was no significant between-groups difference in creatinine at 72 hours (mean difference, -0.57 mg/dl; 95% confidence interval, -1.18, 0.04; P = 0.07). There was no difference in receipt of kidney replacement therapy (14.3% vs. 21.7%, P = 0.34), acute kidney injury (as defined by stage 3 of the Kidney Disease: Improving Global Outcomes acute kidney injury scale; 54.7% vs. 73.9%, P = 0.07), or mortality (35.7% vs. 54.3%, P = 0.14) between the thiamine and placebo groups. Patients who received thiamine had more ICU-free days (median [interquartile range]: 22.5 [0.0-25.0] vs. 0.0 [0.0-23.0], P < 0.01). In the thiamine-deficient cohort (27.4% of patients), there was no difference in rates of kidney failure (57.1% thiamine vs. 81.5% placebo) or in-hospital mortality (28.6% vs. 68.8%) between groups. Conclusions: In the TRPSS trial, there was no statistically significant difference in the primary outcome of change in creatinine over time. Patients who received thiamine had more ICU-free days, but there was no difference in other secondary outcomes. Clinical trial registered with www.clinicaltrials.gov (NCT03550794).
Keywords: kidney injury; sepsis; shock; thiamine.
Figures
Comment in
-
Thiamine for Septic Shock: Take Your Vitamins?Am J Respir Crit Care Med. 2023 Sep 1;208(5):513-515. doi: 10.1164/rccm.202307-1140ED. Am J Respir Crit Care Med. 2023. PMID: 37490623 Free PMC article. No abstract available.
-
The Challenges of Using and Measuring Thiamine in Critical Care.Am J Respir Crit Care Med. 2024 Mar 1;209(5):606-607. doi: 10.1164/rccm.202309-1641LE. Am J Respir Crit Care Med. 2024. PMID: 37972375 Free PMC article. No abstract available.
References
-
- Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med . 2004;351:159–169. - PubMed
-
- Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med . 2008;358:877–887. - PubMed
-
- Kosaka J, Lankadeva YR, May CN, Bellomo R. Histopathology of septic acute kidney injury: a systematic review of experimental data. Crit Care Med . 2016;44:e897–e903. - PubMed
-
- Maiden MJ, Otto S, Brealey JK, Finnis ME, Chapman MJ, Kuchel TR, et al. Structure and function of the kidney in septic shock. A prospective controlled experimental study. Am J Respir Crit Care Med . 2016;194:692–700. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical